Clinical Trial Update: A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating subcutaneous NNC0487-0111 in adults with overweight or obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED